These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15946013)

  • 1. The sensitivity of antibody detection testing using pooled versus unpooled reagent red cells.
    Shulman IA; Nakayama R; Calderon C
    Immunohematology; 1991; 7(1):16-9. PubMed ID: 15946013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Using Genotyped Reagent Red Blood Cells in Antibody Identification.
    Scharberg E; Rink G; Portegys J; Rothenberger S; Gillhuber N; Richter E; Bugert P
    Transfus Med Hemother; 2018 Jul; 45(4):218-224. PubMed ID: 30283270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-A in neonatal serum.
    Mintz PD; Anderson G
    Transfusion; 1991 Sep; 31(7):631-2. PubMed ID: 1891792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of immortalized human erythroid progenitor cell line in serologic tests to detect red blood cell alloantibodies.
    Kikuchi G; Kurita R; Ogasawara K; Isa K; Tsuneyama H; Nakamura Y; Yabe R; Shiba M; Tadokoro K; Nagai T; Satake M
    Transfusion; 2018 Nov; 58(11):2675-2682. PubMed ID: 30180269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and evaluation of false-negative antibody screens.
    Powers A; Chandrashekar S; Mohammed M; Uhl L
    Transfusion; 2010 Mar; 50(3):617-21. PubMed ID: 19951323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new solid-phase immunoassay for alloantibody detection using bromelin-treated and untreated red blood cells.
    Tamai T; Mazda T
    Immunohematology; 2001; 17(1):17-21. PubMed ID: 15373599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect antiglobulin test-crossmatch using low-ionic-strength saline-albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization.
    Dinardo CL; Bonifácio SL; Mendrone A
    Immunohematology; 2014; 30(1):1-5. PubMed ID: 25238242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete pretransfusion testing leads to surgical delays.
    McWilliams B; Yazer MH; Cramer J; Triulzi DJ; Waters JH
    Transfusion; 2012 Oct; 52(10):2139-44; quiz 2145. PubMed ID: 22348700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misidentification of anti-Vel due to inappropriate use of prewarming and adsorption techniques.
    Storry JR; Mallory D
    Immunohematology; 1994; 10(3):83-6. PubMed ID: 15945800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to co-trimoxazole (trimethoprim and/or sulfamethoxazole) related to the presence of the drug in a commercial low-ionic-strength solution.
    Pham BN; Gien D; Bensaad F; Babinet J; Dubeaux I; Rouger P; Le Pennec PY
    Transfusion; 2012 Apr; 52(4):844-8. PubMed ID: 21910740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity of antibody detection testing using pooled versus unpooled reagent red cells.
    Gutendorf RW; Balakrishnan K; Taylor D; Cox K
    Immunohematology; 1991; 7(2):43-5. PubMed ID: 15946020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for RBC antibodies-what should we expect from antibody detection RBCs.
    Garratty G
    Immunohematology; 2002; 18(3):71-7. PubMed ID: 15373554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precipitation of serum proteins by polyethylene glycol (PEG) in pretransfusion testing.
    Hoffer J; Koslosky WP; Gloster ES; Dimaio TM; Reid ME
    Immunohematology; 1999; 15(3):105-7. PubMed ID: 15373511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies in Rh(D) typing of sensitized red blood cells using monoclonal/polyclonal anti-D reagents: case report and review.
    Padget BJ; Hannon JL
    Immunohematology; 2001; 17(1):10-3. PubMed ID: 15373597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Ge2: further evidence for lack of clinical significance.
    Karunasiri D; Lowder F; Ostrzega N; Goldfinger D
    Immunohematology; 2014; 30(4):156-7. PubMed ID: 25831262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.
    Arndt P; Garratty G; Isaak E; Bolger M; Lu Q
    Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do patients with autoantibodies or clinically insignificant alloantibodies require an indirect antiglobulin test crossmatch?
    Lee E; Redman M; Burgess G; Win N
    Transfusion; 2007 Jul; 47(7):1290-5. PubMed ID: 17581166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hemolytic transfusion reactions following emergency-release RBC transfusion.
    Goodell PP; Uhl L; Mohammed M; Powers AA
    Am J Clin Pathol; 2010 Aug; 134(2):202-6. PubMed ID: 20660321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct antiglobulin ("Coombs") test-negative autoimmune hemolytic anemia: a review.
    Segel GB; Lichtman MA
    Blood Cells Mol Dis; 2014 Apr; 52(4):152-60. PubMed ID: 24411920
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.